Skip to content

Brachiocephalic Arteriovenous Fistulae: Two Different Techniques of Bloodless Surgery and Their Effect on Fistula Stenosis.

Brachiocephalic Arteriovenous Fistulae: Two Different Techniques of Bloodless Surgery and Their Effect on Fistula Stenosis.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04402775
Acronym
ABAS
Enrollment
25
Registered
2020-05-27
Start date
2016-04-30
Completion date
2018-07-31
Last updated
2020-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Fistula, Stenosis, Tourniquet

Brief summary

Patients with a chronic kidney disease who opt for hemodialysis, needs a well-functioning hemodialysis access. The autologous arteriovenous fistula (AVF) is recognized as the golden standard of dialysis access. Unfortunately a great number of the AVFs fail to mature, and therefore cannot be used for dialysis. A significant stenosis is a major cause of nonmaturing AVFs. Remarkable are the stenoses that seem to develop in the venous outflow tract where the vascular clamp was located during surgery. The primary aim of this study was to compare bloodless surgery using vascular clamps and a tourniquet with respect to the development of hemodynamic or anatomical significant stenosis in patients with a brachiocephalic or radiocephalic AVF.

Detailed description

Patients with a chronic kidney disease who opt for hemodialysis, needs a well-functioning hemodialysis access. The autologous arteriovenous fistula (AVF) is the golden standard of dialysis access. Unfortunately a great number of the AVFs fail to mature, and therefore cannot be used for dialysis. A significant stenosis is a major cause of nonmaturing AVFs. Remarkable are the stenoses that seem to develop in the venous outflow tract where the vascular clamp was located during surgery. The primary aim of this study was to compare bloodless surgery using vascular clamps and a tourniquet with respect to the development of hemodynamic or anatomical significant stenosis in patients with a brachiocephalic or radiocephalic AVF.

Interventions

OTHERTourniquet

A tourniquet will be used during surgery

Sponsors

HagaZiekenhuis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Patients eligible for the trial were randomly allocated to the tourniquet group (intervention) or vascular clamp group (control)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Mentally competent * Written informed consent * Age 18 years and older * Indication for brachiocephalic AVF in HagaZiekenhuis * Patient is able to complete the follow-up evaluation

Exclusion criteria

* Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Stenosis postoperative (duplex ultrasonography)6 weeksLuminal vessel diameter

Secondary

MeasureTime frameDescription
AVF occlusionWithin 3 months after surgeryAVF occlusion
BleedingWithin 3 months after surgeryBleeding
Duration of surgeryDuring surgeryDuration of surgery in minutes
PseudoaneurysmWithin 3 months after surgeryPseudoaneurysm
Need for reintervention1 year postoperativeSurgical or endovascular reintervention
InfectionWithin 3 months after surgeryInfection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026